A Longitudinal Study of Plasma pTau181 in Mild Cognitive Impairment with Lewy Bodies and Alzheimer's Disease

Concomitant neurodegenerative pathologies contribute to the transition from mild cognitive impairment to dementia

(2021) Kirsty E. McAleese et al.   Alzheimers & Dementia

Progression to Dementia in Mild Cognitive Impairment With Lewy Bodies or Alzheimer Disease

(2021) Calum A. Hamilton et al.   NEUROLOGY

Accuracy of Cardiac Innervation Scintigraphy for Mild Cognitive Impairment With Lewy Bodies

(2021) Gemma Roberts et al.   NEUROLOGY

Hippocampal and insula volume in mild cognitive impairment with Lewy bodies

(2021) Michael J. Firbank et al.   PARKINSONISM & RELATED DISORDERS

Biomarkers for neurodegenerative diseases

(2021) Oskar Hansson   NATURE MEDICINE

Prediction of future Alzheimer’s disease dementia using plasma phospho-tau combined with other accessible measures

(2021) Sebastian Palmqvist et al.   NATURE MEDICINE

Association of Plasma p-tau181 and p-tau231 Concentrations With Cognitive Decline in Patients With Probable Dementia With Lewy Bodies

(2021) Maria C. Gonzalez et al.   JAMA Neurology

Plasma P-tau181 in Alzheimer’s disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer’s dementia

(2020) Shorena Janelidze et al.   NATURE MEDICINE

Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts

(2020) Thomas K Karikari et al.   LANCET NEUROLOGY

Research criteria for the diagnosis of prodromal dementia with Lewy bodies

(2020) Ian G. McKeith et al.   NEUROLOGY

Prospective predictors of decline v. stability in mild cognitive impairment with Lewy bodies or Alzheimer's disease

(2020) Calum A. Hamilton et al.   PSYCHOLOGICAL MEDICINE

Plasma p-tau181 accurately predicts Alzheimer’s disease pathology at least 8 years prior to post-mortem and improves the clinical characterisation of cognitive decline

(2020) Juan Lantero Rodriguez et al.   ACTA NEUROPATHOLOGICA

Subtypes of dementia with Lewy bodies are associated with α-synuclein and tau distribution

(2020) Tanis J. Ferman et al.   NEUROLOGY

Diagnostic performance and prediction of clinical progression of plasma phospho-tau181 in the Alzheimer’s Disease Neuroimaging Initiative

(2020) Thomas K. Karikari et al.   MOLECULAR PSYCHIATRY

Mild cognitive impairment with Lewy bodies: neuropsychiatric supportive symptoms and cognitive profile

(2020) Paul C Donaghy et al.   PSYCHOLOGICAL MEDICINE

Accuracy of dopaminergic imaging as a biomarker for mild cognitive impairment with Lewy bodies

(2020) Gemma Roberts et al.   BRITISH JOURNAL OF PSYCHIATRY

Plasma Phospho‐Tau Identifies Alzheimer's Co‐Pathology in Patients with Lewy Body Disease

(2020) Sara Hall et al.   MOVEMENT DISORDERS

Cardiac 123I-MIBG normal uptake values are population-specific: Results from a cohort of controls over 60 years of age

(2019) G. Roberts et al.   JOURNAL OF NUCLEAR CARDIOLOGY

Amyloid Imaging and Longitudinal Clinical Progression in Dementia With Lewy Bodies

(2019) Paul C. Donaghy et al.   AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY

Person-specific contribution of neuropathologies to cognitive loss in old age

(2018) Patricia A. Boyle et al.   ANNALS OF NEUROLOGY

Diagnosis and management of dementia with Lewy bodies

(2017) Ian G. McKeith et al.   NEUROLOGY

Mortality in dementia with Lewy bodies compared with Alzheimer’s dementia: a retrospective naturalistic cohort study

(2017) Annabel Price et al.   BMJ Open

Alzheimer's disease cerebrospinal fluid biomarkers predict cognitive decline in lewy body dementia

(2016) Carla Abdelnour et al.   MOVEMENT DISORDERS

Cognitive decline in dementia with Lewy bodies: a 5-year prospective cohort study

(2016) A Rongve et al.   BMJ Open

Clinical usefulness of dopamine transporter SPECT imaging with 123I-FP-CIT in patients with possible dementia with Lewy bodies: Randomised study

(2015) Zuzana Walker et al.   BRITISH JOURNAL OF PSYCHIATRY

Cortical Lewy bodies and Aβ burden are associated with prevalence and timing of dementia in Lewy body diseases

(2015) C. Ruffmann et al.   NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY

Clinicians' ability to diagnose dementia with Lewy bodies is not affected by  -amyloid load

(2015) P. Tiraboschi et al.   NEUROLOGY

Cognitive impairment, decline and fluctuations in older community-dwelling subjects with Lewy bodies

(2012) J. A. Schneider et al.   BRAIN

The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease

(2011) Guy M. McKhann et al.   Alzheimers & Dementia

The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease

(2011) Marilyn S. Albert et al.   Alzheimers & Dementia

Diagnostic accuracy of 123I-FP-CIT SPECT in possible dementia with Lewy bodies

(2009) John T. O'Brien et al.   BRITISH JOURNAL OF PSYCHIATRY